Metabolic Diseases and Down Syndrome: How Are They Linked Together?
- PMID: 33671490
- PMCID: PMC7926648
- DOI: 10.3390/biomedicines9020221
Metabolic Diseases and Down Syndrome: How Are They Linked Together?
Abstract
Down syndrome is a genetic disorder caused by the presence of a third copy of chromosome 21, associated with intellectual disabilities. Down syndrome is associated with anomalies of both the nervous and endocrine systems. Over the past decades, dramatic advances in Down syndrome research and treatment have helped to extend the life expectancy of these patients. Improved life expectancy is obviously a positive outcome, but it is accompanied with the need to address previously overlooked complications and comorbidities of Down syndrome, including obesity and diabetes, in order to improve the quality of life of Down syndrome patients. In this focused review, we describe the associations between Down syndrome and comorbidities, obesity and diabetes, and we discuss the understanding of proposed mechanisms for the association of Down syndrome with metabolic disorders. Drawing molecular mechanisms through which Type 1 diabetes and Type 2 diabetes could be linked to Down syndrome could allow identification of novel drug targets and provide therapeutic solutions to limit the development of metabolic and cognitive disorders.
Keywords: central regulation food intake; diabetes; down syndrome; endocrine disorders; immune system; inflammation; obesity; thyroid dysfunction.
Conflict of interest statement
The authors declared no conflict of interest.
Figures
Similar articles
-
Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.Rev Endocr Metab Disord. 2019 Jun;20(2):239-250. doi: 10.1007/s11154-019-09502-2. Rev Endocr Metab Disord. 2019. PMID: 31065942 Review.
-
[Affective disorders: endocrine and metabolic comorbidities].Encephale. 2014 Dec;40 Suppl 3:S33-9. doi: 10.1016/S0013-7006(14)70129-0. Encephale. 2014. PMID: 25550238 French.
-
Care of Adults With Intellectual and Developmental Disabilities: Down Syndrome.FP Essent. 2015 Dec;439:20-5. FP Essent. 2015. PMID: 26669211 Review.
-
Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems.J Affect Disord. 2017 Mar 15;211:99-106. doi: 10.1016/j.jad.2016.12.059. Epub 2017 Jan 4. J Affect Disord. 2017. PMID: 28107669 Review.
-
Down syndrome--genetic and nutritional aspects of accompanying disorders.Rocz Panstw Zakl Hig. 2015;66(3):189-94. Rocz Panstw Zakl Hig. 2015. PMID: 26400113 Review.
Cited by
-
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions.Front Mol Neurosci. 2024 Jul 24;17:1391564. doi: 10.3389/fnmol.2024.1391564. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39114642 Free PMC article. Review.
-
Diabetes and Obesity in Down Syndrome Across the Lifespan: A Retrospective Cohort Study Using U.K. Electronic Health Records.Diabetes Care. 2022 Sep 30;45(12):2892-9. doi: 10.2337/dc22-0482. Online ahead of print. Diabetes Care. 2022. PMID: 36178378 Free PMC article.
-
Weight loss in adolescents with down syndrome compared to adolescents with other intellectual disabilities enrolled in an 18-month randomized weight management trial.Front Pediatr. 2022 Nov 2;10:1022738. doi: 10.3389/fped.2022.1022738. eCollection 2022. Front Pediatr. 2022. PMID: 36405842 Free PMC article.
-
Analysis of Dietary Habits and Nutritional Status of Children with Down Syndrome in the Context of Lipid and Oxidative Stress Parameters.Nutrients. 2022 Jun 9;14(12):2390. doi: 10.3390/nu14122390. Nutrients. 2022. PMID: 35745122 Free PMC article.
-
Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome.J Endocrinol Invest. 2023 Nov;46(11):2319-2325. doi: 10.1007/s40618-023-02086-4. Epub 2023 Apr 11. J Endocrinol Invest. 2023. PMID: 37040064
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous